Cardinal Health, Inc. (CAH) Holdings Trimmed by Stephens Inc. AR
Stephens Inc. AR lowered its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 6.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,951 shares of the company’s stock after selling 475 shares during the period. Stephens Inc. AR’s holdings in Cardinal Health were worth $542,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Bronfman E.L. Rothschild L.P. raised its stake in Cardinal Health by 31.8% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 1,583 shares of the company’s stock valued at $123,000 after acquiring an additional 382 shares in the last quarter. JFS Wealth Advisors LLC raised its stake in Cardinal Health by 14.3% during the 2nd quarter. JFS Wealth Advisors LLC now owns 1,949 shares of the company’s stock valued at $152,000 after acquiring an additional 244 shares in the last quarter. Dupont Capital Management Corp bought a new stake in Cardinal Health during the 2nd quarter valued at $164,000. First Personal Financial Services raised its stake in Cardinal Health by 127.5% during the 2nd quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock valued at $172,000 after acquiring an additional 1,238 shares in the last quarter. Finally, Alpha Windward LLC raised its stake in Cardinal Health by 0.7% during the 2nd quarter. Alpha Windward LLC now owns 2,299 shares of the company’s stock valued at $179,000 after acquiring an additional 17 shares in the last quarter. 87.63% of the stock is currently owned by hedge funds and other institutional investors.
Cardinal Health, Inc. (CAH) opened at 67.07 on Tuesday. Cardinal Health, Inc. has a one year low of $62.70 and a one year high of $84.88. The firm has a market capitalization of $21.22 billion, a PE ratio of 16.64 and a beta of 0.85. The company has a 50 day moving average price of $68.00 and a 200-day moving average price of $74.84.
Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.24 by $0.07. The company had revenue of $32.97 billion for the quarter, compared to the consensus estimate of $32.73 billion. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. The firm’s quarterly revenue was up 5.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.14 EPS. On average, equities analysts predict that Cardinal Health, Inc. will post $4.96 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Sunday, October 15th. Stockholders of record on Monday, October 2nd will be paid a $0.4624 dividend. This represents a $1.85 dividend on an annualized basis and a dividend yield of 2.76%. The ex-dividend date of this dividend is Friday, September 29th. Cardinal Health’s dividend payout ratio (DPR) is currently 45.79%.
TRADEMARK VIOLATION WARNING: “Cardinal Health, Inc. (CAH) Holdings Trimmed by Stephens Inc. AR” was originally published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://theolympiareport.com/2017/09/19/cardinal-health-inc-cah-holdings-trimmed-by-stephens-inc-ar.html.
Several analysts have weighed in on the company. Royal Bank Of Canada assumed coverage on Cardinal Health in a research note on Tuesday. They set a “sector perform” rating and a $72.00 target price on the stock. Robert W. Baird reaffirmed a “hold” rating and set a $73.00 target price on shares of Cardinal Health in a research note on Sunday. Needham & Company LLC reaffirmed a “hold” rating on shares of Cardinal Health in a research note on Sunday, September 10th. Jefferies Group LLC set a $77.00 target price on Cardinal Health and gave the company a “hold” rating in a research note on Tuesday, August 29th. Finally, BidaskClub downgraded Cardinal Health from a “sell” rating to a “strong sell” rating in a research note on Wednesday, August 16th. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have given a buy rating to the stock. Cardinal Health has a consensus rating of “Hold” and an average target price of $77.91.
About Cardinal Health
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.